Subscribe To
Biontech posts tripled q1 vaccine sales but still flags full-year decline
BioNTech said first-quarter sales and earnings more than tripled thanks to demand for the COVID-19 vaccine it developed with Pfizer, but the German ...
May 9, 2022, 6:11 am
Chemocentryx: a biotech stock well worth the risk
In the wake of its first quarter earnings report, ChemoCentryx ran as much as 25% on Friday as the broader market fell. The move could mark an importa...
May 9, 2022, 4:00 am
Longeveron: small-cap biotech targeting large alzheimer's market
A phase 2a study using Lomecel-B for Alzheimer's Disease is currently enrolling patients; a prior phase 1 study established excellent safety profile w...
May 6, 2022, 2:32 pm
Battered biotech space now unbelievably inexpensive
After disappointing in 2021, biotechnology stocks and exchange traded funds are getting shellacked this year as growth stocks fall out of favor due to...
May 6, 2022, 12:54 pm
Q biomed says its strategy is paying off as it outlines its value proposition in multibillion-dollar markets
Q BioMed Inc told investors that it had studiously avoided biotech single-asset risks by acquiring mult...
May 6, 2022, 10:41 am
Puma biotechnology, inc. (pbyi) ceo alan auerbach on q1 2022 results - earnings call transcript
Puma Biotechnology, Inc. (NASDAQ:PBYI ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Mariann Ohanesian - Senior Direct...
May 5, 2022, 10:05 pm
Oncolytics biotech, inc. (oncy) ceo matthew coffey on q1 2022 results - earnings call transcript
Oncolytics Biotech, Inc. (NASDAQ:ONCY ) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Corporate Participants Jon Patton - Director, Investor...
May 5, 2022, 9:55 pm
Vir biotechnology, inc. (vir) q1 earnings and revenues beat estimates
Vir Biotechnology, Inc. (VIR) delivered earnings and revenue surprises of 19.94% and 80.87%, respectively, for the quarter ended March 2022. Do the nu...
May 5, 2022, 6:48 pm
Why biocryst stock lost nearly 4% of its value today
The biotech whiffs on both revenue and profitability for its first quarter, and indicates more losses a...
May 5, 2022, 6:10 pm
Brickell biotech to report first quarter 2022 financial results and provide a corporate update on may 12, 2022
BOULDER, Colo., May 05, 2022 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmace...
May 5, 2022, 4:01 pm
This stock is trouncing the market in 2022 -- and its prospects just got even better
The big biotech's winning ways are likely to continue....
May 5, 2022, 5:52 am
Adaptive biotechnologies reports $38.6m in q1 revenue as it repositions following job cuts
Adaptive Biotechnologies announced its first quarter earnings Wednesday, two months after laying off 12% of its workforce....
May 4, 2022, 5:45 pm
Should you invest in the ishares biotechnology etf (ibb)?
Sector ETF report for IBB...
May 4, 2022, 7:31 am
Brickell biotech shares surge after offloading late-stage asset to australia-based firm
Brickell biotech Inc (NASDAQ: BBI) agreed to sell sofpironium bromide rights to Australia-based Bot...
May 4, 2022, 6:50 am
5 graham's lost formula biotech stocks to consider for may
After a brutal month in April, U.S. market indexes were lower on Tuesday as investors await the Federal Open Market Committee's decision on interest r...
May 3, 2022, 4:35 pm
Spro stock alert: 9 things to know as spero therapeutics plunges 50%
Spero Therapeutics (SPRO) stock is taking a beating on Tuesday after the biotech company revealed a cha...
May 3, 2022, 11:23 am
Lexagene's miqlab system successfully detects biohazard agents in us army r&d test
LexaGene Holdings Inc (TSX-V:LXG, OTCQB:LXXGF) announced that its MiQLab automated rapid pathogen testing device has successfully completed tests fo...
May 3, 2022, 9:14 am
Orgenesis says consortium led by its mida biotech subsidiary wins 4 million euro grant supporting cutting edge technology
Orgenesis (NASDAQ:ORGS) Inc said that a consortium led by its subsidiary, MIDA Biotech, has won a 4-million-euro grant under the European Innovation ...
May 3, 2022, 7:52 am
Vera therapeutics selected to present interim phase 2 data for mau868 to treat bk virus in kidney transplant patients as oral late-breaker at the american transplant congress 2022
BRISBANE, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late-stage biotechnology company focused on developing an...
May 2, 2022, 7:06 pm
Drug/biotech stocks q1 earnings due on may 3: pfe, biib & more
Let's look at the five biotech/pharma companies, slated to release quarterly results on May 3....
May 2, 2022, 5:18 pm